Notch and TLRs Cross Paths in the Innate Immune System
Notch 和 TLR 在先天免疫系统中交叉
基本信息
- 批准号:7943669
- 负责人:
- 金额:$ 5.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-20 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigensAwardBiologyBorreliaBorrelia burgdorferiCell physiologyCellsCellular biologyCollaborationsCollectionComplementDataDevelopmentDoctor of PhilosophyDrug Delivery SystemsEducational process of instructingElectronic MailEnvironmentExperimental Autoimmune EncephalomyelitisFacultyFlow CytometryFosteringFundingGenerationsGermanyGoalsGrantHeadHealthHome environmentHost DefenseHumanImmune responseImmune systemImmunologyIn VitroInfectionInflammatoryInstitutionInterleukin-6JapanJournalsKnowledgeLaboratoriesLearningLeptospira interrogansLeptospirosisLettersLifeLinkMAP Kinase GeneMassachusettsMediatingMembraneMentorsMicrobiologyMissionMusNF-kappa BNatureNew EnglandNotch Signaling PathwayOccupationsOutcomeParentsPathway interactionsPlayPositioning AttributeProcessProductionReagentReceptor SignalingRegulatory T-LymphocyteResearchResearch PersonnelRewardsRoleScientistSeminalSeriesSignal PathwaySignal TransductionSiteStudentsSystemT-Cell ActivationT-LymphocyteTLR2 geneTLR4 geneTechnologyTechnology TransferTestingTh1 CellsThailandTimeToll-like receptorsTrainingTravelUniversitiesVisitWorkWritingcytokinedefense responsedesignexperienceimmune functionin vivoinhibitor/antagonistinsightinterestknockout animallecturerlymphocyte proliferationmacrophagemeetingsnotch proteinnoveloverexpressionparent grantpathogenpost-doctoral trainingprofessorprogramspublic health relevancereceptor bindingresearch studyresponsesecretaseskillssymposiumtool
项目摘要
DESCRIPTION (provided by applicant): The ability to mount an effective immune response to pathogens requires a functional innate immune system. The innate immune system provides the first line of defense against infection. Toll-like receptors (TLR), a collection of membrane bound receptors found on many cells of the innate system, are molecules that drive important signaling pathways mediating the innate immune response. The importance of TLRs is highlighted by studies employing mice where components of the TLR signaling pathway are deleted. Loss of TLR signaling severely compromises innate immune responses and renders the host highly susceptible to infection. During the past year, several laboratories, including our own, have shown that TLR signaling, in addition to activating NF-kB and MAPK pathways, also activates the Notch signaling pathway. In this application, we propose that Notch activation, a newly described and novel target of TLR signaling, also influences innate immunes responses to the pathogen Borrelia burgdorferi. The experiments proposed in this application are designed to unravel the mechanism by which TLR signaling leads to Notch activation and may suggest novel drug targets for modulating immune responses. A second and equally important component of this application is to foster research partnerships between NIH-supported scientists (Osborne) and collaborators in the developing world (Palaga). The aims of this proposal are designed to extend an important and novel observation made by the LMIC investigator and the PI and to enhance research environment at the LMIC site as well as train an LMIC student in the PI's laboratory. The overarching goal of this application is to utilize our novel preliminary data to promote scientific collaboration and exchange between the two laboratories. Although Borrelia is not a pathogen endemic to the LMIC site, Thailand, Borrelia signals through TLR2, a signaling pathway used by many pathogens endemic in Thailand. Our studies proposed in this application will provide a framework for the LMIC investigator to investigate the role of Notch signaling in response to these pathogens. The research in this application will be conducted, in part, at Chulalongkorn University, Bangkok, Thailand and directed by Dr. Tanapat Palaga. This project is linked to parent grant PO1 AG025531, Barbara A. Osborne, PI (7/1/06-6/30/11).
PUBLIC HEALTH RELEVANCE: The aims of this application will describe novel mechanisms that mediate the innate immune response to pathogens. Innate immune responses are critical for the clearance of most pathogens. Therefore studies that provide insight into these processes have high impact on human health. This application will be conducted in conjunction with an LMIC investigator at Chulalongkorn University in Bangkok, Thailand and will aid research efforts and training of students at the LMIC institution.
描述(由申请人提供):对病原体有效反应的能力需要一种功能性的先天免疫系统。先天免疫系统提供了针对感染的第一道防线。 Toll样受体(TLR)是在先天系统的许多细胞上发现的膜结合受体的集合,是驱动介导先天免疫反应的重要信号通路的分子。通过使用TLR信号通路组件的小鼠的研究,TLR的重要性强调了。 TLR信号的丧失严重损害了先天免疫反应,并使宿主极易受到感染的影响。在过去的一年中,包括我们自己的几个实验室,还表明,除了激活NF-KB和MAPK途径外,TLR信号传导还激活了Notch信号通路。在此应用中,我们建议Notch激活是TLR信号传导的新靶标,也影响了先天免疫对病原体Borrelia burgdorferi的反应。本应用程序中提出的实验旨在揭示TLR信号导致Notch激活的机制,并可能建议调节免疫反应的新型药物靶标。 该应用程序的第二个也同样重要的组成部分是促进NIH支持的科学家(Osborne)与发展中国家合作者(Palaga)之间的研究伙伴关系。该提案的目的旨在扩展LMIC研究者和PI的重要和新颖的观察结果,并在LMIC站点增强研究环境,并在PI实验室培训LMIC学生。该应用程序的总体目标是利用我们的新型初步数据来促进两个实验室之间的科学协作和交流。尽管伯氏菌不是LMIC部位的病原体,但泰国,通过TLR2信号是TLR2的信号,TLR2是泰国许多病原体使用的信号传导途径。我们在本应用中提出的研究将为LMIC研究者提供一个框架,以研究Notch信号对这些病原体的作用。 该申请中的研究将部分在泰国曼谷朱拉隆科大学进行,并由Tanapat Palaga博士执导。该项目链接到父母授予PO1 AG025531,Barbara A. Osborne,PI(7/1/06-6/30/11)。
公共卫生相关性:该应用程序的目的将描述介导对病原体的先天免疫反应的新型机制。先天免疫反应对于大多数病原体的清除至关重要。因此,提供有关这些过程的洞察力的研究对人类健康有很大影响。该申请将与泰国曼谷Chulalongkorn University的LMIC研究员一起进行,并将帮助LMIC机构的研究工作和培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA A OSBORNE其他文献
BARBARA A OSBORNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA A OSBORNE', 18)}}的其他基金
Cellular Engineering Biotechnology Training Program
细胞工程生物技术培训项目
- 批准号:
8794847 - 财政年份:2015
- 资助金额:
$ 5.96万 - 项目类别:
Targeting Multiple Diseases Through Gamma Secretase
通过伽玛分泌酶针对多种疾病
- 批准号:
8738618 - 财政年份:2013
- 资助金额:
$ 5.96万 - 项目类别:
Targeting Multiple Diseases Through Gamma Secretase
通过伽玛分泌酶针对多种疾病
- 批准号:
9040465 - 财政年份:2013
- 资助金额:
$ 5.96万 - 项目类别:
Targeting Multiple Diseases Through Gamma Secretase
通过伽玛分泌酶针对多种疾病
- 批准号:
8415150 - 财政年份:2013
- 资助金额:
$ 5.96万 - 项目类别:
Notch and TLRs Cross Paths in the Innate Immune System
Notch 和 TLR 在先天免疫系统中交叉
- 批准号:
8318163 - 财政年份:2010
- 资助金额:
$ 5.96万 - 项目类别:
Notch and TLRs Cross Paths in the Innate Immune System
Notch 和 TLR 在先天免疫系统中交叉
- 批准号:
8132992 - 财政年份:2010
- 资助金额:
$ 5.96万 - 项目类别:
Targeting Multiple Diseases Through Gamma Secretase
通过伽玛分泌酶针对多种疾病
- 批准号:
7258361 - 财政年份:2006
- 资助金额:
$ 5.96万 - 项目类别:
Targeting Multiple Diseases Through Gamma Secretase
通过伽玛分泌酶针对多种疾病
- 批准号:
7883268 - 财政年份:2006
- 资助金额:
$ 5.96万 - 项目类别:
相似国自然基金
非洲猪瘟病毒B475L蛋白靶向LMP2抑制抗原递呈的分子机制
- 批准号:32302894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于HBV和肝癌相关抗原免疫优势T细胞表位的双靶人工抗原提呈细胞治疗HBV相关肝癌的研究
- 批准号:82303729
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
KIF17介导肿瘤细胞MHC-II胞膜定位促进乳腺癌抗原提呈及免疫应答的机制研究
- 批准号:82372781
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
微量肝癌组织肿瘤新抗原高效稳定深度覆盖鉴定技术研究
- 批准号:32371503
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
钩吻素子对胃癌MHC-I类抗原呈递激活免疫应答的调控及其机制研究
- 批准号:82373138
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 5.96万 - 项目类别:
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 5.96万 - 项目类别:
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
SPORE 德克萨斯大学 MD 安德森癌症中心 - 白血病
- 批准号:
10911713 - 财政年份:2023
- 资助金额:
$ 5.96万 - 项目类别:
Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients
开发新型小分子 RPN13 抑制剂和治疗晚期卵巢癌患者的药物
- 批准号:
10760824 - 财政年份:2023
- 资助金额:
$ 5.96万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 5.96万 - 项目类别: